[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE03920B1 - Bensoksasinoonide asümmeetriline sünteesimine - Google Patents

Bensoksasinoonide asümmeetriline sünteesimine

Info

Publication number
EE03920B1
EE03920B1 EEP199900243A EE9900243A EE03920B1 EE 03920 B1 EE03920 B1 EE 03920B1 EE P199900243 A EEP199900243 A EE P199900243A EE 9900243 A EE9900243 A EE 9900243A EE 03920 B1 EE03920 B1 EE 03920B1
Authority
EE
Estonia
Prior art keywords
alkyl
give
asymmetric synthesis
agent
alkylthio
Prior art date
Application number
EEP199900243A
Other languages
English (en)
Estonian (et)
Other versions
EE9900243A (et
Inventor
Ernest Pierce Michael
Choudhury Anusuya
Lawrence Parsons Rodney Jr.
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of EE9900243A publication Critical patent/EE9900243A/xx
Publication of EE03920B1 publication Critical patent/EE03920B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EEP199900243A 1996-12-16 1997-12-15 Bensoksasinoonide asümmeetriline sünteesimine EE03920B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3298096P 1996-12-16 1996-12-16
US08/838,838 US5932726A (en) 1996-12-16 1997-04-11 Asymmetric synthesis of benzoxazinones
PCT/US1997/022674 WO1998027073A1 (en) 1996-12-16 1997-12-15 Asymmetric synthesis of benzoxazinones

Publications (2)

Publication Number Publication Date
EE9900243A EE9900243A (et) 1999-12-15
EE03920B1 true EE03920B1 (et) 2002-12-16

Family

ID=26709131

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900243A EE03920B1 (et) 1996-12-16 1997-12-15 Bensoksasinoonide asümmeetriline sünteesimine

Country Status (27)

Country Link
US (1) US5932726A (xx)
EP (1) EP0944610B1 (xx)
JP (1) JP4232911B2 (xx)
KR (1) KR100498665B1 (xx)
CN (1) CN1075063C (xx)
AT (1) ATE289296T1 (xx)
AU (1) AU750047B2 (xx)
BR (1) BR9714031A (xx)
CA (1) CA2275323C (xx)
CZ (1) CZ297168B6 (xx)
DE (1) DE69732525T2 (xx)
EA (1) EA002987B1 (xx)
EE (1) EE03920B1 (xx)
ES (1) ES2235265T3 (xx)
HR (1) HRP970688A2 (xx)
HU (1) HU225655B1 (xx)
IL (2) IL130684A (xx)
LV (1) LV12432B (xx)
NO (1) NO313236B1 (xx)
NZ (1) NZ336163A (xx)
PL (1) PL192661B1 (xx)
PT (1) PT944610E (xx)
RO (1) RO120844B1 (xx)
SI (1) SI20071A (xx)
SK (1) SK285258B6 (xx)
UA (1) UA66773C2 (xx)
WO (1) WO1998027073A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874430A (en) * 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
TWI326283B (en) * 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
AU2003248217A1 (en) * 2003-04-04 2004-10-25 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
WO2010032259A2 (en) 2008-05-30 2010-03-25 Emcure Pharmaceuticals Limited Novel process
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
CN101844990B (zh) * 2010-05-27 2013-03-20 浙江沙星医药化工有限公司 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法
EP2441759A1 (en) 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
CN103664816B (zh) * 2011-01-06 2016-03-02 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺
WO2015118515A1 (en) * 2014-02-10 2015-08-13 Discovery Intermediates Private Limited An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor
EP2944631A1 (en) * 2014-05-12 2015-11-18 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of Efavirenz
CN104016936B (zh) * 2014-06-18 2016-08-17 中国科学院上海有机化学研究所 手性氨基酚配体在依法韦仑不对称合成中的应用
CN105801442A (zh) * 2015-10-16 2016-07-27 浙江沙星医药化工有限公司 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法
EP3388460A4 (en) * 2015-12-08 2019-05-22 DIC Corporation OXAZINE COMPOUND, COMPOSITION AND CURED PRODUCT
CN108368216B (zh) * 2015-12-08 2020-09-18 Dic株式会社 恶嗪化合物、组合物及固化物
WO2017098925A1 (ja) * 2015-12-08 2017-06-15 Dic株式会社 オキサジン化合物、組成物及び硬化物
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE343057C (de) * 1914-06-21 1921-10-25 Kalle & Co Aktien Ges Verfahren zur Darstellung von 1-Arylamino-4-oxynaphthalinen
US3280120A (en) * 1964-03-09 1966-10-18 Rexall Drug Chemical Substituted benzoxazines, process therefor and intermediates
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3513166A (en) * 1967-05-22 1970-05-19 Robins Co Inc A H 3-(omega-aminoalkyl)-4-substituted-1,3-benzoxazine-2-ones
AU5960380A (en) * 1979-08-30 1981-03-05 A. Ehrenreich G.m.b.H. & Co. KG Bellows seal and retaining ring
DE3622262A1 (de) * 1986-07-02 1988-01-07 Bayer Ag Chromogene 3,1-benzoxazine
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

Also Published As

Publication number Publication date
PL192661B1 (pl) 2006-11-30
UA66773C2 (uk) 2004-06-15
US5932726A (en) 1999-08-03
AU5694498A (en) 1998-07-15
EE9900243A (et) 1999-12-15
LV12432B (en) 2000-07-20
WO1998027073A1 (en) 1998-06-25
KR100498665B1 (ko) 2005-07-01
PL334281A1 (en) 2000-02-14
SK285258B6 (sk) 2006-10-05
NO313236B1 (no) 2002-09-02
CA2275323C (en) 2003-04-08
HU225655B1 (en) 2007-05-29
CZ212899A3 (cs) 1999-11-17
AU750047B2 (en) 2002-07-11
NO992914L (no) 1999-06-15
RO120844B1 (ro) 2006-08-30
JP4232911B2 (ja) 2009-03-04
CN1245493A (zh) 2000-02-23
WO1998027073A8 (en) 1999-11-04
DE69732525D1 (de) 2005-03-24
IL130684A0 (en) 2000-06-01
CA2275323A1 (en) 1998-06-25
EP0944610A1 (en) 1999-09-29
HUP0000168A2 (hu) 2000-09-28
CZ297168B6 (cs) 2006-09-13
KR20000057574A (ko) 2000-09-25
SK80399A3 (en) 2000-03-13
EA002987B1 (ru) 2002-12-26
CN1075063C (zh) 2001-11-21
NZ336163A (en) 2001-04-27
PT944610E (pt) 2005-04-29
ATE289296T1 (de) 2005-03-15
EP0944610B1 (en) 2005-02-16
SI20071A (sl) 2000-04-30
HRP970688A2 (en) 1998-10-31
HUP0000168A3 (en) 2001-02-28
JP2001507684A (ja) 2001-06-12
ES2235265T3 (es) 2005-07-01
DE69732525T2 (de) 2006-01-12
LV12432A (lv) 2000-02-20
EA199900552A1 (ru) 2000-02-28
IL130684A (en) 2003-12-10
NO992914D0 (no) 1999-06-15
BR9714031A (pt) 2000-05-09

Similar Documents

Publication Publication Date Title
EE9900243A (et) Bensoksasinoonide asümmeetriline sünteesimine
DE59806330D1 (de) Synergistische Flammschutzmittel-Kombination für Kunststoffe
TR200400376T4 (tr) Yeni, ilaç olarak kullanılabilen antikolinerjikler ve bunların imalatı için yöntem
FR2699918B1 (fr) Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
PT73338A (de) 3,1-benzoxazin-2-one ihre herstellung und verwendung
ES8401030A1 (es) Un procedimiento para la preparacion de indol sulfonilureas.
DE68908643D1 (de) Mercapto-phenylalkanoylaminosäure-Amide, deren Herstellung und deren Verwendung als Collagenase-Inhibitoren.
ATE133938T1 (de) Indan-1,3-dion und indan-1,2,3-trionderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
GB2183476B (en) Anthihypertensive combination product
ATE83234T1 (de) Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung.
ATE131167T1 (de) Verfahren zur herstellung von ergolinderivaten.
ATE1904T1 (de) 2-sulfonyl-chinoxaline, verfahren zu ihrer herstellung sowie ihre verwendung als mikrobizide.
PE119599A1 (es) Tetrahidronaftalenos sustituidos y compuestos analogos
MX9302388A (es) Oxazolidinonas fungicidas y composicion fungicida que las contiene
ATE97409T1 (de) Benzodiazepin-analoge.
DE59712054D1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE69420179D1 (de) 2-Aminopyrazin-5-carbonsäureamid Derivate, deren Herstellung und deren Verwendung als Heilmittel
ATE12767T1 (de) Substituierte oximinoacetanilide, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel.
MX9801955A (es) Mezclas herbicidas con accion sinergetica.
ECSP951529A (es) Compuestos farmaceuticos
MX9703235A (es) Fenil alquil cetona substituida por amina ciclica y un procedimiento para su preparacion.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231